Skip to main content
Premium Trial:

Request an Annual Quote

Face Time, Dead-End Projects, and Success

At his blog, Anthony Fejes says successful graduate students are often those who spend more time with their PIs, know when to drop dead-end projects, and are clear on their personal definitions of success. While trainees do not always have control over how much time they spend with their advisors, Fejes says that those who spend the most time with their PIs benefit from the "opportunity to learn more from those who already know something about a field; more input … from those who have made the mistakes; and access to more hot topic projects."

Knowing when to let go, he adds, "is a huge determining factor" of a graduate students' success. "Those students around me who are able to move from project to project quickly are the ones that get the most papers and opportunities," Fejes says.

As for the defining success, Fejes says it's critical that graduate students consider how their personal goals mesh with what is expected of them. "In academia, at least for grad students, success isn't necessary measured with the same metrics. Instead, it seems to be measured by how many scholarships you get and how many first author papers you publish," he says.

There are, of course, other factors at play. Though students' success is somewhat dependent on the resources available to them, Fejes says the ability to network effectively is a learned skill, which can be compensatory. "Fortunately, networking can also be done for cheap, such as blogs and twitter," he says. "You may have to go out of the way to make them happen, but you can do it if you invest your (limited) time wisely."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.